Connect with us

Business

Social media ads for prescription-only weight-loss medicines banned

Published

on

Social media ads for prescription-only weight-loss medicines banned



The first Instagram, TikTok and Facebook posts by members of the public promoting weight-loss jabs have been banned by the advertising regulator.

The posts used discount codes and referral links to advertise the injections, including Mounjaro, for the online pharmacies Voy, Zava, MedExpress and the online prescribing service UK Meds Direct, the Advertising Standards Authority (ASA) said.

Weight-loss injections are a prescription-only medicine and therefore cannot be advertised to the public.

Affiliate or referral schemes typically allow individuals to share links or discount codes and give them a reward or other benefit if someone else uses them.

The ASA warned that, in practice, this could mean members of the public promoting prescription-only medicines to friends, family, followers and the public, sometimes without realising that their posts may be ads or that strict rules apply to them.

The regulator said its rulings made clear that both brands and individuals are responsible for sticking to advertising rules, and that posts that include affiliate or referral schemes can still count as ads, even if they appear on personal social media accounts.

The banned posts promoted the medicines by naming them directly, using related hashtags, showing images of injection pens or encouraging followers to start their own weight-loss ‘journey’, alongside offering discounts or incentives.

The ASA ruled that they were advertising prescription-only medicines because they were public posts.

It also found that although the companies had not directly asked for the posts to be made, they did control how their affiliate and referral schemes worked.

This meant they were also responsible for making sure the advertising rules were followed.

The ASA warned that weight-loss prescription drugs were powerful medicines that should be used only under the supervision of a qualified medical professional, adding: “Promoting them irresponsibly and illegally can put people at serious risk, which is why this is a priority area for us.”

Catherine Drewett, investigations manager at the ASA, said: “Today’s rulings send a clear message that affiliate marketing is not a loophole and that promoting prescription medicines through social media, whether as a brand, influencer or customer, is against the law and our rules.

“We’ll continue take swift action in this area to make sure the rules are followed and that people are protected from harmful and irresponsible ads.”

A spokeswoman for Voy said: “The posts referenced in the ruling were made independently by customers of our service back in 2024 as part of a referral scheme for our weight-loss programme.

“These posts were first brought to our attention in June 2025, and since we have strengthened our controls around referral activity and influencer engagement. Clinical decisions — including whether medication is suitable — are always made privately between patients and qualified clinicians, and no influencers or referrers play any role in diagnosis, prescribing or medical advice.”

Zava said: “We are committed to being a responsible and compliant healthcare organisation that follows regulation and guidance from the ASA.

“While we were disappointed by the ruling, we note that we had no commercial or affiliate relationship with the social media users who created the posts in question, and as a business we do not have oversight or control over content shared independently by members of the public on their own social media channels.”

Julian Beach, interim executive director of healthcare quality and access at the Medicines and Healthcare products Regulatory Agency (MHRA), said: “We welcome today’s rulings from the ASA. Prescription-only weight-loss medicines carry real risks and must only be prescribed following a proper clinical assessment.

“The promotion of these medicines through affiliate schemes and social media circumvents important safeguards that exist to protect patients.

“We will continue to work closely with the ASA and General Pharmaceutical Council (GPhC) to take action against those who break the rules and put people’s health at risk.”

Dionne Spence, chief enforcement officer at the GPhC, said: “These rulings from the ASA send a clear message that online providers are responsible for making sure that advertising rules are followed, including when working with individuals through affiliate or referral schemes.

“We welcome the action taken by the ASA and we have taken action to follow up with the pharmacies registered with us.”



Source link

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Business

RBI raises ceiling for unsecured loans of UBCs to 25% of total advances

Published

on

RBI raises ceiling for unsecured loans of UBCs to 25% of total advances


New Delhi: The Government of India and the Reserve Bank of India (RBI) have taken various measures to strengthen cooperative banks’ financial health, governance and digital inclusion along with enhancing deposit security, credit availability and prudent regulation, said Minister of State in the Ministry of Finance, Pankaj Chaudhary, in Rajya Sabha on Tuesday.

As part of efforts to support business expansion, Urban Cooperative Banks (UCBs) have been permitted to open new branches, enabling wider outreach and improved customer access. In a move aimed at boosting credit flow, the permissible housing loan exposure of UCBs has been raised to 25 per cent of their total loans and advances, from the earlier limit of 10 per cent.

To improve governance continuity, amendments to the Banking Regulation Act have increased the maximum tenure of directors of cooperative banks from eight years to ten years, allowing experienced boards to provide longer-term oversight.

Add Zee News as a Preferred Source


To promote digital payments and financial inclusion, the licensing fee for onboarding cooperative banks to the Aadhaar Enabled Payment System (AePS) has been reduced, lowering entry barriers for smaller institutions.

The government has also strengthened institutional support for cooperative banks through the creation of new entities. The National Urban Co-operative Finance and Development Corporation Limited (NUCFDC) was established as a non-deposit-taking, non-banking financial company to serve as an umbrella organisation for UCBs, providing information technology infrastructure and operational support.

For rural institutions, a Shared Services Entity (SSE) named Sahakar Sarthi has been established to deliver common technological services to Rural Cooperative Banks, improving efficiency and reducing operational costs.

Further strengthening customer protection, Rural Cooperative Banks have been brought under the RBI’s Integrated Ombudsman Scheme, providing customers with access to a unified grievance redressal mechanism.

On deposit safety, the Deposit Insurance and Credit Guarantee Corporation (DICGC) continues to insure deposits of all cooperative banks up to Rs 5 lakh per depositor per bank, including both principal and interest, providing enhanced confidence to depositors.

Recently, it was also announced that loans sanctioned by banks to the National Cooperative Development Corporation (NCDC), as of January 19, 2026, for on-lending to cooperative societies, are eligible for classification as priority sector lending under the respective categories.

 



Source link

Continue Reading

Business

Estée Lauder sues Walmart alleging ‘despicable’ sale of counterfeit beauty products

Published

on

Estée Lauder sues Walmart alleging ‘despicable’ sale of counterfeit beauty products


Walmart Inc. signage during the company’s listing at the Nasdaq MarketSite in New York, US, on Tuesday, Dec. 9, 2025.

Michael Nagle | Bloomberg | Getty Images

Estée Lauder sued Walmart in California federal court over allegations the big-box retailer sold counterfeit beauty products on its website and didn’t do enough to ensure only authorized and authentic merchandise was offered to consumers. 

Estée Lauder said it purchased, inspected or tested a number of products sold on Walmart.com that used the Le Labo, La Mer, Clinique, Aveda, Tom Ford and Estée Lauder trademarks but were determined to be fakes, according to the suit, filed Monday.

The products include counterfeit versions of Estée Lauder’s Advanced Night Repair serum, a Le Labo fragrance, a Clinique eye cream, a La Mer lotion, an Aveda hair brush and a Tom Ford fragrance. 

xemplars of the Estée Lauder Accused Products

U.S. District Court Complaint

It’s unclear when Estée Lauder bought and tested the products but the suit comes several months after CNBC published an investigation into counterfeit beauty products and fraud on Walmart.com.

Two of the counterfeit products cited in CNBC’s investigation — Estee Lauder Advanced Night Repair serum and Clinique Smart Clinical Repair Wrinkle Correcting Eye Cream — were also mentioned in Estée Lauder’s lawsuit. It’s unclear if the products cited in the suit are the same counterfeits CNBC provided to Estée Lauder. 

In response, Walmart initially told CNBC in a statement it requires “all sellers to offer only authentic, lawful merchandise” and it doesn’t tolerate “bad actors” on its platform. It then recalled the message and sent an abbreviated statement to CNBC two hours later that removed that language.

“We are aware of the complaint and have zero tolerance for counterfeit products,” the revised statement read. “We will respond appropriately with the court when we are served.” 

Estée Lauder didn’t return a request for comment. 

Exemplars of the Clinique Accused Products

U.S. District Court Complaint

While the products were sold by third-party sellers on Walmart’s online marketplace, Estée Lauder said the company played an active role in facilitating those sales to shoppers in its suit. The legacy beauty company called Walmart’s conduct “extreme, outrageous, fraudulent … despicable and harmful.” 

The counterfeit products were promoted and advertised to shoppers on the platform, Estee Lauder’s trademarks were used in search engine optimization tools to drive traffic to the listings and Walmart profited from the sales, the complaint stated. 

Further, “a person shopping on Walmart.com would have reasonably believed that Walmart, and not third-party sellers, was the seller” of the item, which could have caused confusion among shoppers, the complaint states. 

At the heart of CNBC’s investigation into Walmart’s online marketplace was the steps the company took, or didn’t take, to vet its third-party sellers and the products they were offering to prevent fraud and the sale of fakes on the platform. 

Exemplars of the La Mer Accused Products.

U.S. District Court Complaint

In its complaint, Estée Lauder said Walmart promoted the “reputation and professionalism” of the sellers permitted to operate on the platform but said the retailer actually does “very little to ensure that only authorized and authentic products are available” for sale. 

“This is readily apparent given the [counterfeits] were permitted to be sold on Defendants’ website despite their stated careful selection process in who they choose as a Marketplace seller/partner,” the complaint states. “Accordingly, Defendants know or had reason to know that the sellers they partnered with and ‘regularly review[ed]’ were selling products which infringe upon the Estée Lauder Marks.” 

Walmart’s online marketplace has become a key part of its strategy to grow profit faster than sales and better compete against its longtime rival, Amazon. The rapid growth of the online platform helped fuel Walmart’s ascent to a $1 trillion market cap last week, putting it in an exclusive club made up almost entirely of technology companies. 

However, the strategy has come with risks, CNBC’s investigation revealed. Offering counterfeit, potentially dangerous, products to shoppers through third-party sellers on the marketplace opens Walmart up to liability and could erode the customer trust at the core of its brand.

Exemplars of the Le Labo Accused Products

U.S. District Court Complaint

Ever since a 2010 court ruling that arose after Tiffany sued eBay over counterfeit products on the platform, it can be tough for brands to hold platforms accountable for their role in selling counterfeit goods. Sometimes, they avoid lawsuits unless the conduct is extreme or particularly flagrant, experts previously told CNBC.

The Shop Safe Act, a bipartisan federal bill that aims to curb the sale of fakes on online marketplaces, is designed to address some of the issues posed by the Tiffany v. eBay ruling by incentivizing platforms to better vet sellers and the products they’re offering. When platforms comply with certain anti-counterfeiting measures, they could be shielded from liability if a seller offers a fake product. 

Brands widely supported the legislation, but it has so far failed to pass at least three times. That’s partially because Walmart and other online marketplaces like Amazon, Etsy and eBay have lobbied against aspects of it, two U.S. Senate aides, who spoke on the condition of anonymity because the discussions were private, previously told CNBC. 



Source link

Continue Reading

Business

‘Menacing’ Disney advert featuring severed body banned

Published

on

‘Menacing’ Disney advert featuring severed body banned


Disney subsidiary Twentieth Century Studios, which produced the film, said it was rated 12A, and the advertisement had been designed with that in mind. The company argued the brief and stylised nature of the scene meant the alien character or other imagery used would be unlikely to cause harm or offence.



Source link

Continue Reading

Trending